Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Anticoagulation".)
International
●International Society on Thrombosis and Haemostasis (ISTH): Guidance for the identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer (2017)
●ISTH: Recommendations for the assessment of non-extremity venous thromboembolism outcomes (2014)
Canada
●Thrombosis Canada (TC): Clinical guides
●Canadian Association of Gastroenterology (CAG): Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease (2014)
United States
●American Society of Hematology (ASH): Guidelines for management of venous thromboembolism – Treatment of pediatric venous thromboembolism (2018)
●Eastern Association for the Surgery of Trauma (EAST) and the Pediatric Trauma Society (PTS): A practice management guideline on prophylaxis against venous thromboembolism in pediatric trauma (2017)
●Pediatric Cardiac Intensive Care Society (PCICS): Consensus statement on pharmacotherapies in cardiac critical care anticoagulation and thrombolysis, 2014 (published 2016)
●AHA: A scientific statement on the postthrombotic syndrome – Evidence-based prevention, diagnosis, and treatment strategies (2014)
●AHA: A scientific statement for prevention and treatment of thrombosis in pediatric and congenital heart disease (2013)
●American College of Chest Physicians (CHEST): Evidence-based clinical practice guidelines on antithrombotic therapy and prevention of thrombosis, 9th edition – Antithrombotic therapy in neonates and children (2012)
Europe
●The Single Hub and Access point for paediatric Rheumatology in Europe (SHARE): European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome (2017)
United Kingdom
●British Society for Haematology (BSH): Guideline for management of thrombotic and haemostatic issues in paediatric malignancy (2018)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on antithrombotics – Indications and management (2012)
●British Committee for Standards in Haematology (BCSH) and BSH: Guideline on the investigation, management, and prevention of venous thrombosis in children (2011)
Australia–New Zealand
●Choosing Wisely Australia: Do not extend anticoagulation beyond 3 months for a patient with a non-extensive, index venous thromboembolic event (VTE), which occurred in the setting of a major, transient risk factor (2015)
Japan
●[In Japanese] Japanese Circulation Society (JCS): Guidelines for diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (2017, updated 2020)
